- Home
- PVBC vs GNFT Comparison
PVBC vs GNFT Comparison
Compare PVBC & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVBC
- GNFT
- Stock Information
- Founded
- PVBC 1913
- GNFT 1999
- Country
- PVBC United States
- GNFT France
- Employees
- PVBC N/A
- GNFT N/A
- Industry
- PVBC Major Banks
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PVBC Finance
- GNFT Health Care
- Exchange
- PVBC Nasdaq
- GNFT Nasdaq
- Market Cap
- PVBC 208.3M
- GNFT 179.7M
- IPO Year
- PVBC 2015
- GNFT 2019
- Fundamental
- Price
- PVBC $12.31
- GNFT $3.74
- Analyst Decision
- PVBC Hold
- GNFT Strong Buy
- Analyst Count
- PVBC 1
- GNFT 1
- Target Price
- PVBC $12.00
- GNFT $13.00
- AVG Volume (30 Days)
- PVBC 23.3K
- GNFT 9.9K
- Earning Date
- PVBC 01-23-2025
- GNFT 09-19-2024
- Dividend Yield
- PVBC N/A
- GNFT N/A
- EPS Growth
- PVBC N/A
- GNFT N/A
- EPS
- PVBC 0.43
- GNFT 0.47
- Revenue
- PVBC $55,400,000.00
- GNFT $86,225,222.00
- Revenue This Year
- PVBC N/A
- GNFT $145.20
- Revenue Next Year
- PVBC $5.07
- GNFT N/A
- P/E Ratio
- PVBC $28.26
- GNFT $7.89
- Revenue Growth
- PVBC N/A
- GNFT 175.45
- 52 Week Low
- PVBC $7.36
- GNFT $3.35
- 52 Week High
- PVBC $12.40
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- PVBC 59.52
- GNFT 49.41
- Support Level
- PVBC $11.65
- GNFT $3.68
- Resistance Level
- PVBC $12.40
- GNFT $4.03
- Average True Range (ATR)
- PVBC 0.31
- GNFT 0.15
- MACD
- PVBC 0.11
- GNFT 0.05
- Stochastic Oscillator
- PVBC 67.61
- GNFT 57.35
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.